Advances in structure-based drug design: The potential for precision therapeutics in psychiatric disorders
Neuron · 2024-02 · 112 (4) · 526-538
DOI: 10.1016/j.neuron.2024.01.004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neuron, 2024-02. Verfasst von Dongmei Cao und 2 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Molecular Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chin…. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Mental Disorders. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Ministry of Science and Technology of the People's Republic of China.
Abstract (Originalsprache)
Over the years, the field of GPCR drug design has undergone a remarkable evolution, fueled by advancements in science and technology. This evolution has given rise to a diverse range of ideas and approaches in structure-based drug design, bolstering the versatility and strength of the GPCR drug design toolbox. This review encapsulates the iterative development process, navigating challenges and opportunities in structure-based drug design within GPCRs. With a focused emphasis on its impact on psychiatric disorders, the review accentuates recent advancements and delves into the potentials unlocked by emerging technologies. The review explores the intricate interplay between scientific progress and iterative refinement, offering profound insights into the potential pathways that lie ahead for GPCR drug design.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Molecular Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Sh…
Förderung
- National Natural Science Foundation of China
- Ministry of Science and Technology of the People's Republic of China
Zitieren
APA
Cao, D., Zhang, P., & Wang, S. (2024). Advances in structure-based drug design: The potential for precision therapeutics in psychiatric disorders. Neuron, 112(4), 526-538. https://doi.org/10.1016/j.neuron.2024.01.004
Vancouver
Cao D, Zhang P, Wang S. Advances in structure-based drug design: The potential for precision therapeutics in psychiatric disorders. Neuron. 2024;112(4):526-538. doi:10.1016/j.neuron.2024.01.004
BibTeX
@article{Cao2024,
author = {Cao, Dongmei and Zhang, Pei and Wang, Sheng},
title = {Advances in structure-based drug design: The potential for precision therapeutics in psychiatric disorders},
journal = {Neuron},
year = {2024},
volume = {112},
number = {4},
pages = {526--538},
doi = {10.1016/j.neuron.2024.01.004}
}
EUVIMED